NurExone Biologic (FRA:J90) FFO


FRA:J90 NurExone Biologic Inc FRA:J90
40 GF Score
Price €0.29
! 2 Warning Signs
View Full Analysis

What is NurExone Biologic FFO?

FFO (Funds from operations) only applies to REITs.

FRA:J90
40GF Score
NurExone Biologic Inc FRA:J90
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NurExone Biologic Business Description

Other Exchanges NRXBF:USANRX:Canada
Address 1 Adelaide Street East, Suite 801, Toronto, ON, CAN, M5C 2V9
NurExone Biologic Inc is a company that focuses on developing biological and minimally invasive treatments for Spinal Cord Injury and Traumatic Brain Injury. Its primary product is ExoTherapy, which is an exosome therapy production platform. It is developing ExoPTEN, a product that utilizes ExoTherapy for the treatment of acute Spinal Cord Injuries (SCI). It also aims to monetize its proprietary ExoTherapy technology and production platform by licensing it to the biopharmaceutical industry for other diseases and indications.
40GF Score

Get the complete analysis for FRA:J90

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.29
Price